Medical Research
(H50Z)
IRS Verified
DX Registered
990 on File
CHILDRENS TUMOR FOUNDATION
Financial strength (30%)
82/100
Reliability (20%)
55/100
Effectiveness (25%)
88/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$19.7M
Total Revenue
$19.0M
Total Expenses
$26.8M
Net Assets
55
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
83.8%
Fundraising Efficiency
693.4%
Operating Reserve
16.90x
Liability-to-Asset
12.7%
Revenue Diversification
95.7%
Executive Compensation
$1.6M
Compared with Peers
FY 2024
Compared with 98 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
83.8% | 82.0% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
8.0% | 12.7% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
8.2% | 0.7% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
693.4% | 693.4% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
16.9 mo | 14.5 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
12.7% | 21.3% |
P10P90
|
Above median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
95.7% | 90.8% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
20.0% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
1.0% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
3.7% | -1.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $19.7M | $19.0M | $26.8M | 83.8% | 55 |
| 2023 | $16.4M | $18.8M | $25.7M | 83.8% | 53 |
| 2022 | $17.0M | $15.8M | $27.6M | 85.1% | 48 |
| 2021 | $16.8M | $10.4M | N/A | — | 43 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.